Alpha 2.0
Login Register
» Authors » Michela Trada

Michela Trada

Explore the profile of Michela Trada including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 11
Citations 76
Followers 0
Related Specialties
Endocrinology
Pediatrics
General Medicine
Top 10 Co-Authors
Davide Tinti
Ivana Rabbone
Riccardo Schiaffini
Luisa de Sanctis
Dario Iafusco
Maurizio Delvecchio
Angela Zanfardino
Barbara Predieri
Stefano Zucchini
Carlo Ripoli
Published In
Diabetes Obes Metab
Front Endocrinol (Lausanne)
Ital J Pediatr
Acta Diabetol
Front Med (Lausanne)
Affiliations
Soon will be listed here.
Recent Articles
1.
Diagnosis and Treatment of Neonatal Diabetes Caused by ATP-Channel Mutations: Genetic Insights, Sulfonylurea Therapy, and Future Directions
Trada M, Novara C, Moretto M, Burzi E, Tinti D, de Sanctis L
Children (Basel) . 2025 Feb; 12(2). PMID: 40003320
Background: Neonatal diabetes (NDM) is a rare genetic disorder diagnosed in infants under six months of age, characterized by persistent hyperglycemia resulting from insufficient or absent insulin production. Unlike the...
2.
Paediatric type 1 diabetes mellitus: A comparison between multi-injection therapy and advanced hybrid closed-loop pump in the first year after diabetes onset
Tinti D, Nobili C, Baretta I, Rosso A, Trada M, de Sanctis L
Diabetes Obes Metab . 2024 Jun; 26(9):4100-4104. PMID: 38860411
No abstract available.
3.
The real-life management of glucose homeostasis abnormalities in pediatric onco-hematological diseases: data from a national survey
Zanfardino A, Bruzzi P, Trada M, Rapini N, Laudani E, Tornese G, et al.
Pediatr Hematol Oncol . 2024 Jan; 41(3):198-210. PMID: 38269620
Glycemic abnormalities are a frequent finding in pediatric oncological patients, both during treatment and after its discontinuation. Moreover, impaired glucose tolerance (IGT), impaired fasting glycemia (IFG) and diabetes mellitus (DM)...
4.
Nasal glucagon is safe and effective in children and adolescents with type 1 diabetes: A real-world prospective cohort study
Zucchini S, Ripoli C, Cherubini V, Coccioli M, Delvecchio M, De Marco R, et al.
Diabetes Obes Metab . 2023 Oct; 26(2):754-757. PMID: 37867226
No abstract available.
5.
Corrigendum: The silent epidemic of diabetic ketoacidosis at diagnosis of type 1 diabetes in children and adolescents in italy during the covid-19 pandemic in 2020
Cherubini V, Marino M, Scaramuzza A, Tiberi V, Bobbio A, Delvecchio M, et al.
Front Endocrinol (Lausanne) . 2022 Aug; 13:977211. PMID: 35992112
[This corrects the article .].
6.
Increase in newly diagnosed type 1 diabetes and serological evidence of recent SARS-CoV-2 infection: Is there a connection?
Denina M, Trada M, Tinti D, Funiciello E, Novara C, Moretto M, et al.
Front Med (Lausanne) . 2022 Aug; 9:927099. PMID: 35966867
Several studies have investigated the correlation between the COVID-19 pandemic and the onset of type 1 diabetes (T1D) in children, reporting an increased incidence of T1D and severe diabetic ketoacidosis...
7.
The Silent Epidemic of Diabetic Ketoacidosis at Diagnosis of Type 1 Diabetes in Children and Adolescents in Italy During the COVID-19 Pandemic in 2020
Cherubini V, Marino M, Scaramuzza A, Tiberi V, Bobbio A, Delvecchio M, et al.
Front Endocrinol (Lausanne) . 2022 Jul; 13:878634. PMID: 35784550
Aim/hypothesis: To compare the frequency of diabetic ketoacidosis (DKA) at diagnosis of type 1 diabetes in Italy during the COVID-19 pandemic in 2020 with the frequency of DKA during 2017-2019....
8.
Effectiveness of a closed-loop control system and a virtual educational camp for children and adolescents with type 1 diabetes: A prospective, multicentre, real-life study
Cherubini V, Rabbone I, Berioli M, Giorda S, Lo Presti D, Maltoni G, et al.
Diabetes Obes Metab . 2021 Jul; 23(11):2484-2491. PMID: 34227214
Aim: To evaluate the impact of a virtual educational camp (vEC) on glucose control in children and adolescents with type 1 diabetes using a closed-loop control (CLC) system. Materials And...
9.
Impact of lockdown during COVID-19 emergency on glucose metrics of children and adolescents with type 1 diabetes in Piedmont, Italy
Tinti D, Savastio S, Grosso C, De Donno V, Trada M, Nugnes M, et al.
Acta Diabetol . 2021 Mar; 58(7):959-961. PMID: 33721077
No abstract available.
10.
Differences between transient neonatal diabetes mellitus subtypes can guide diagnosis and therapy
Bonfanti R, Iafusco D, Rabbone I, Diedenhofen G, Bizzarri C, Patera P, et al.
Eur J Endocrinol . 2021 Feb; 184(4):575-585. PMID: 33606663
Objective: Transient neonatal diabetes mellitus (TNDM) is caused by activating mutations in ABCC8 and KCNJ11 genes (KATP/TNDM) or by chromosome 6q24 abnormalities (6q24/TNDM). We wanted to assess whether these different...